Effect of SA4503, a novel sigma1 receptor agonist, against glutamate neurotoxicity in cultured rat retinal neurons

European Journal of Pharmacology
T SendaAkinori Akaike

Abstract

We examined the effects of sigma1 receptor agonists against glutamate-induced neurotoxicity in cultured retinal neurons. Primary cultures obtained from fetal rat retinas (16-19 d gestation) were used. The neurotoxic effect of glutamate was quantitatively assessed using the trypan blue exclusion method. A brief exposure of retinal cultures to glutamate (500 microM) led to delayed neuronal cell death. The glutamate-induced neurotoxicity was inhibited by (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo-[a,b]-cyclohepten-5 ,10-imine hydrogen maleate (MK-801). The sigma1 receptor agonists, 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydrochloride (SA4503) and (+)-pentazocine at a concentration range of 0.1 approximately 100 microM reduced the glutamate-induced neurotoxicity in a dose-dependent manner. In addition, the neuroprotective effects of both SA4503 and (+)-pentazocine were antagonized by co-treatment with N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine monohydrochloride (NE-100), a putative sigma1 receptor antagonist. These findings suggest that sigma1 receptor agonists protect retinal cells against glutamate-induced neurotoxicity.

References

Oct 1, 1976·General Pharmacology·M J Neal
Mar 1, 1992·Trends in Pharmacological Sciences·R QuirionD P Taylor
Jul 1, 1992·Journal of Neurochemistry·P Louzada-JúniorJ Coutinho-Netto
Sep 1, 1992·Stroke; a Journal of Cerebral Circulation·P G LyskoG Feuerstein
Mar 1, 1992·Stroke; a Journal of Cerebral Circulation·P G LyskoG Feuerstein
Mar 1, 1991·Brain Research Bulletin·M J PontecorvoJ W Ferkany
Sep 22, 1991·The Journal of Comparative Neurology·S DavangerJ Storm-Mathisen
Jul 9, 1990·Brain Research·B GottiB Scatton
Sep 1, 1990·Trends in Pharmacological Sciences·B Meldrum, J Garthwaite
Mar 31, 1988·Nature·M SarantisD Attwell
Mar 1, 1989·Archives of Ophthalmology·Y H Yoon, M F Marmor
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·E H WongL L Iversen
Aug 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·C Brandon, D M Lam
Mar 1, 1995·Naunyn-Schmiedeberg's Archives of Pharmacology·M TanakaS Otomo
Jan 1, 1993·Life Sciences·S OkuyamaM Yoshida
Jan 15, 1994·European Journal of Pharmacology·A CagnottoT Mennini
Jun 13, 1996·European Journal of Pharmacology·K MatsunoS Mita

❮ Previous
Next ❯

Citations

Nov 1, 2001·Brain Research. Molecular Brain Research·M S OlaS B Smith
Aug 5, 2000·Progress in Retinal and Eye Research·P Heiduschka, S Thanos
Jul 14, 2005·Neuroreport·Claudio BucoloVenkat N Reddy
Feb 24, 2015·Journal of Pharmacological Sciences·Linda NguyenRae R Matsumoto
Jun 10, 2015·Journal of Receptor and Signal Transduction Research·Colin G Rousseaux, Stephanie F Greene
Sep 15, 2004·European Journal of Pharmacology·Claudio Bucolo, Filippo Drago
Apr 21, 2018·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Anna KlassEdgar Santos
Jan 24, 2015·Journal of Neuroscience Research·Daisuke YamashitaTatsuo Matsunaga
Feb 8, 2006·Neuroreport·Claudio BucoloVenkat N Reddy
Nov 9, 2002·Journal of Neurophysiology·Trent R Anderson, R David Andrew
Feb 24, 2012·The Journal of Pharmacology and Experimental Therapeutics·Cheng-Wei LuSu-Jane Wang
Nov 3, 2020·Investigative Ophthalmology & Visual Science·Jing WangSylvia B Smith
Jul 27, 2021·Frontiers in Physiology·Richa AishwaryaMd Shenuarin Bhuiyan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.